These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 35010954)

  • 1. Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment.
    Adinew GM; Taka E; Mochona B; Badisa RB; Mazzio EA; Elhag R; Soliman KFA
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
    Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
    Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Targeting Potential of Thymoquinone for Therapeutic Intervention Against Triple-negative Breast Cancer.
    Barkat MA; Harshita ; Ahmad J; Khan MA; Beg S; Ahmad FJ
    Curr Drug Targets; 2018; 19(1):70-80. PubMed ID: 28606050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment.
    Wu TN; Chen HM; Shyur LF
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
    Zajac KK; Malla S; Babu RJ; Raman D; Tiwari AK
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1779. PubMed ID: 36632988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoquinone Inhibition of Chemokines in TNF-α-Induced Inflammatory and Metastatic Effects in Triple-Negative Breast Cancer Cells.
    Adinew GM; Messeha S; Taka E; Mochona B; Redda KK; Soliman KFA
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting.
    Furukawa N; Stearns V; Santa-Maria CA; Popel AS
    Expert Opin Ther Targets; 2022 Dec; 26(12):1041-1056. PubMed ID: 36657483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
    Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
    Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
    Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N
    Gene; 2021 Aug; 792():145728. PubMed ID: 34022297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone, a bioactive component of black caraway seeds, causes G1 phase cell cycle arrest and apoptosis in triple-negative breast cancer cells with mutant p53.
    Sutton KM; Greenshields AL; Hoskin DW
    Nutr Cancer; 2014; 66(3):408-18. PubMed ID: 24579801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy.
    Mahmoud YK; Abdelrazek HMA
    Biomed Pharmacother; 2019 Jul; 115():108783. PubMed ID: 31060003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies.
    Zou Z; Luo T; Wang X; Wang B; Li Q
    J Cell Physiol; 2024 Aug; 239(8):e31278. PubMed ID: 38807378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells: Their role in triple-negative breast cancer progression and metastasis.
    Malla RR; Vasudevaraju P; Vempati RK; Rakshmitha M; Merchant N; Nagaraju GP
    Cancer; 2022 Mar; 128(6):1171-1183. PubMed ID: 34990009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.
    Qattan A
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymoquinone upregulates IL17RD in controlling the growth and metastasis of triple negative breast cancer cells in vitro.
    Khan MA; Zheng M; Fu J; Tania M; Li J; Fu J
    BMC Cancer; 2022 Jun; 22(1):707. PubMed ID: 35761256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231.
    Sjs B; K K; A P; P H; B SR; S S
    Drug Dev Ind Pharm; 2021 Dec; 47(12):1943-1951. PubMed ID: 35510706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.
    Cheng N; Bei Y; Song Y; Zhang W; Xu L; Zhang W; Yang N; Bai X; Shu Y; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114298. PubMed ID: 33153969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic Role of Thymoquinone on Anticancer Activity of 5-Fluorouracil in Triple Negative Breast Cancer Cells.
    Zheng M; Mei Z; Junaid M; Tania M; Fu J; Chen HC; Khan MA
    Anticancer Agents Med Chem; 2022; 22(6):1111-1118. PubMed ID: 34170813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor-stromal interactions in triple-negative breast cancer using a human vascularized micro-tumor model.
    Hachey SJ; Hatch CJ; Gaebler D; Mocherla A; Nee K; Kessenbrock K; Hughes CCW
    Breast Cancer Res; 2024 Jan; 26(1):5. PubMed ID: 38183074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.